Fujirebio Europe Receives Translational Research Funding From Alzheimer’s Drug Discovery Foundation for Development of a Fully Automated Plasma pTau181 Testing Solution
H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio, today announced an agreement with the Diagnostics Accelerator initiative of the Alzheimer's Drug Discovery Foundation (ADDF) to accelerate the development of a plasma pTau181 detection assay on the fully automated LUMIPULSE® G immunoassay platform. pTau is recognized as an important fluid biomarker linked to the diagnosis of Alzheimer’s disease (AD). The ADDF Diagnostics Accelerator initiative is part of a collaboration with Gates Ventures and other philanthropic partners.
Blood-based testing could have the potential to become a simple, accessible, and scalable approach to help support the diagnosis of AD. Of all the AD blood biomarkers under investigation, pTau has particular promise1. Access to a fully automated Lumipulse® G plasma pTau181 assay will allow clinicians and clinical research professionals to measure plasma pTau181 levels with a high degree of precision and efficiency. The test could also help simplify AD drug clinical trial recruitment of eligible cohorts.
“We are pleased to begin this cooperation with the ADDF, cementing the active engagement of Fujirebio to reach new milestones in AD testing,” said Christiaan De Wilde, CEO of Fujirebio Europe. “Fujirebio has an unrivalled heritage as a pioneer in the field of AD research, and the desire to tackle this and other neurodegenerative diseases runs deep throughout our teams. The possibility of easily accessible blood tests for the fully automated diagnosis of AD is a breakthrough the world is eagerly waiting for.”
Fujirebio was the first company to develop and market cerebrospinal fluid (CSF) biomarkers under the Innogenetics brand over 25 years ago. Today these products are an essential part of routine AD testing in many parts of the world. Fujirebio remains the only company with such a comprehensive line-up of fully automated AD assays and consistently partners with organizations and clinical experts across the world to develop new pathways for earlier, easier and more complete neurodegenerative diagnostic tools. More information can be found at www.fujirebio.com/alzheimer.
About Fujirebio
Fujirebio is a global leader in the field of in vitro diagnostics (IVD) testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.
About the Diagnostics Accelerator
The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator is a collaborative research initiative funded by leading philanthropists including ADDF Co-Founder Leonard A. Lauder, Bill Gates, Jeff Bezos, MacKenzie Scott, the Dolby family, the Charles and Helen Schwab Foundation, and The Association for Frontotemporal Degeneration among others to fast-track the development of affordable and accessible diagnostic tools and biomarkers for Alzheimer's disease and related dementias.
References
1. Zetterberg & Blennow, Mol Neurodegener 2021; 16 :10.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005491/en/
Contact information
For media:
Christiaan De Wilde
CEO Fujirebio Europe
+32-9329-1703
Public Relations Section, Public Relations/Sustainability Dept.
+81-3-6279-0884
pr@hugp.com
For investors and analysts:
IR/SR Dept.
+81-3-5909-3337
ir@hugp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Veracode Report Finds 63% of Financial Services Firms Carry Critical Security Debt, Heightening Supply Chain Risk29.10.2025 13:50:00 EET | Press release
Veracode, the global leader in application risk management, today released its 2025 State of Software Security (SoSS) Snapshot for the Financial Services Sector. The analysis reveals nearly two-thirds (63 percent) of banking, financial services, and insurance (BFSI) organizations harbor critical security debt—high-severity flaws left unfixed for longer than a year—a rate of 13 percentage points higher than the cross-industry average. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029207424/en/ Fig. 1: Financial service sector flaw remediation timeline based on survival analysis "Trust is everything in financial services, yet our data reveals a silent, growing risk for the sector created by unresolved security debt," said Chris Wysopal, Co-founder & Chief Security Evangelist at Veracode. "With AI-driven attacks surging and compliance requirements tightening, finance leaders must prioritize strategic risk reduction, startin
NuORDER by Lightspeed Extends Partnership with Nordstrom as Retailer Invests in Data-Driven Wholesale Strategies29.10.2025 13:05:00 EET | Press release
NuORDER by Lightspeed, a leading global commerce platform that enables retailers and brands to connect, collaborate, and make smarter buying decisions, today announced Nordstrom is strengthening its partnership with NuORDER by Lightspeed. NuORDER will play a larger role in Nordstrom’s end-to-end data and integration program to enable Nordstrom to further improve their merchandise assortment and customer experience. By creating a universal catalog of product, category, sizing data, and imagery, NuORDER helps Nordstrom operate more efficiently at scale by reducing manual processes and accelerating buying cycles. Today, NuORDER collects over 50 data points per item. As Nordstrom develops AI-powered processes to get merchandise to customers more efficiently, NuORDER will increase data capture to support AI-driven forecasting, product recommendations, and personalization. “Collecting comprehensive product data from thousands of brands is time-intensive, costly, and requires extensive collab
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors29.10.2025 12:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey Jonas to its Board of Directors, effective immediately. Dr. Jonas brings more than three decades of leadership in pharmaceutical research and development, with a particular focus on neuroscience. As part of this Board transition, Thomas Lönngren will retire from his position on the Board at the end of December after more than six years of service. Mr. Lönngren has been an invaluable counselor across the company’s achievements, including the advancement of the COMP360 program and transition from an early-stage to late-stage clinical company. “With Compass leading the field of psychedelics and looking ahead to potential commercialization for COMP360, we are grateful to have Dr. Jonas’ extensive experience in neuroscience, an area in which he has consistently driven breakthroughs in treatment,” s
Tecnotree Maintains Momentum with Sixth Consecutive Quarter of Profit and Cash Flow29.10.2025 11:12:00 EET | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, announced today its Q3 2025 results, summarizing financial performance year-to-date ending 30 September 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029815979/en/ Tecnotree Maintains Momentum with Sixth Consecutive Quarter of Profit and Cash Flow Year-to-Date Financial Highlights as of Q3 2025: Positive free cash flow EUR 3.2 (–2.2) million, sixth consecutive quarter of cash-positive operations. Revenue in constant currency EUR 56.6 (54.0) million, +4.8%. EBIT in constant currency EUR 14.9 (13.0) million, +15.0%. Annual recurring revenue EUR 25.1 (23.2) million, +8%. Order backlog EUR 105.5 (75.1) million, +40%. Commenting on the results for the third quarter of 2025, Padma Ravichander, CEO of Tecnotree, says: “Tecnotree’s Q3 2025 results reflect our disciplined focus on profitable order book execution, with year-to
Domaine Worldwide and Shopify Launch Enterprise Platform Migration Initiative Across Europe29.10.2025 11:00:00 EET | Press release
Domaine Worldwide, the leading global Shopify design and development partner, announced the launch of its European Platform Migrations partnership with Shopify today. The initiative positions Domaine as the go-to commerce partner for enterprise-level brands across the UK, DACH, and BENELUX regions looking to migrate to Shopify’s scalable, commerce-ready infrastructure. As enterprise organizations across Europe face the challenge of modernizing legacy systems, this campaign highlights the combined power of Domaine’s migration expertise and Shopify’s enterprise-grade flexibility—offering brands a seamless path to improved performance, agility, and long-term growth. “For enterprise retailers, platform migration is no longer just a technical decision—it’s a strategic one. For some, it's become a strategic imperative,” said Marko Bon, Co-founder and President of Domaine. “We’ve seen first-hand how a migration to Shopify is a foundational step in digital business transformation, unlocking st
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom